DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea · Delayed Price · Currency is KRW 3,460.00
-40.00 (-1.14%)
Apr 30, 2026, 3:30 PM KST
DK Life Science Market Cap
DK Life Science has a market cap or net worth of 110.67 billion as of April 30, 2026. Its market cap has decreased by -30.59% in one year.
Market Cap
110.67B
Enterprise Value
142.39B
Revenue
130.34B
Ranking
n/a
PE Ratio
12.58
Stock Price
3,460.00
Market Cap Chart
Since February 17, 2025, DK Life Science's market cap has decreased from 200.38B to 110.67B, a decrease of -44.77%. That is a compound annual growth rate of -39.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 110.67B | -5.46% |
| Dec 30, 2025 | 117.06B | -41.58% |
| Feb 17, 2025 | 200.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 69.62T |
| Celltrion | 43.39T |
| ALTEOGEN | 20.15T |
| Samsung Epis Holdings | 14.13T |
| Osang Healthcare Co.,Ltd | 123.72B |
| iNtRON Biotechnology | 119.66B |
| Ildong Holdings | 113.94B |
| Oncocross | 111.59B |